Braveheart Bio's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Braveheart Bio's ROA in the third quarter of 2026?
Braveheart Bio, Inc. recorded a cumulative net loss of $-115 million during 12 months ending in the third quarter of 2026, resulting in a negative return on assets (ROA) of -62.88%.

However, within the Healthcare sector Braveheart Bio, Inc. achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the second quarter of 2026 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) II. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-115	-89	-74	-60	0
Return On Assets (TTM)	-62.88 %	-164.15 %	-330.74 %	-	-
BRVE's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	514	127	89	0	0
Seq. Total Assets Change	305.22 %	42.09 %	-	-	-
Seq. Net Income Change	-	-	-	-	-

BRVE's 5 Years Annual ROA >> Back to BRVE Management Effectiveness >> Compare BRVE ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Braveheart Bio's Assets	$ 514 million	BRVE's Balance sheet
Braveheart Bio's Income	$ -26 million	Quarterly BRVE's Income Statement
BRVE's Income by Division		See BRVE's Income by Division

Annual Return On Assets	FY	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	0	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	0	0	0	0	0
Annual Return On Assets	-	-	-	-	-

BRVE's 5 Years Annual ROA >> Back to BRVE Management Effectiveness >> Compare BRVE ROA to its Competitors

More Return On Assets Ratios
BRVE's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
BRVE's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for BRVE's Competitors
Subscribers only: Roa for Braveheart Bio's Suppliers
Subscribers only: Return On Assets for BRVE's Customers

You may also want to know
BRVE's Roi	BRVE's Inventory Turnover Ratio	BRVE's Growth Rates	BRVE's Dividend Comparisons
	BRVE's Profitability Ratios	BRVE's Asset Turnover Ratio	BRVE's Dividend Growth
BRVE's Roe	BRVE's Valuation Ratios	BRVE's Financial Strength Ratios	BRVE's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector

ROA

Date modified: 2026-11-11T13:35:53+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.